Stroke Flashcards
Tenecteplase
Stroke Indications
Dose
- Acute stroke within 4.5 hours of last known well
- 0.25 mg/kg, maximum 25 mg
Alteplase vs Tenecteplase
Infusion time
Generation
Direct plasminoGEN activator?
Half-life (Min)
Fibrin selectivity
PAI-1 resistance
FDA indications
Plasminogen activator inhibitor-1
60 min vs 5-10 sec
2nd vs 3rd
yes vs yes
4-8 min vs 20-24 (initial) 90-130 (terminal)
++ vs +++
++ vs +++
PE, Stroke, STEMI vs STEMI
UH
1. How is tenecteplase prepared?
- Reconstituted preparation of Tenecteplase contains what concentration of tenecteplase?
- 10 mL of sterile water for injection added into tenecteplase powdered vial
Reconstitute by swirling - DO NOT SHAKE - Tenecteplase 5 mg/mL
How to administer Tenecteplase
Caution when sing Dextrose containing line.
- Should be colorless to pale yellow without any particulates.
- Administer over 5-10 seconds
- Flush IV line prior to and following administration of tenecteplase with saline-containing solution. If not there may be precipitation.
Maximum dose for Tenecteplase
25 mg, thus in a reconstituted 50mg/10mL (administer no more than 5 mL)
Contraindications for Tenecteplase
History of ____ ?
Intracranial hemorrhage
Contraindications for Tenecteplase
Ischemic stroke within ____ (time)?
3 months
Contraindications for Tenecteplase
Symptoms suggestive of ____?
Subarachnoid hemorrhage
Severe headache, photophobia, seizure, loss of consciousness
Contraindications for Tenecteplase
Arterial puncture in ____?
Non-compressible site within 7 days
Contraindications for Tenecteplase
What type of surgery or trauma?
WITHIN 3 MONTHS
Intracranial or spinal sx. Recent significant head trauma.
Contraindications for Tenecteplase
Intracranial pathology
Known structural cerebrovascular disease.
Known intracranial malignant neoplasm
Contraindications for Tenecteplase
Blood pressure, bleeding/CBC
SBP >185 or DBP >110
Active internal bleeding
Bleeding diathesis: platelets <100,000 mm3, aPTT> 40s, PT > 15 s, INR >1.7
Contraindications for Tenecteplase
Anticoagulation- timing of contraindications
Anticoagulation contraindications (last dose within): o Apixiban (Eliquis®) within 48 hours\*\* o Dabigatran (Pradaxa®) within 72 hours\*\* o Enoxaparin (Lovenox®) therapeutic dose within 24 hours\*\* o Heparin therapeutic dose and aPTT \> ULN\*\* o Rivaroxaban (Xarelto®) within 48 hours\*\* o Warfarin (Coumadin®) and INR\> 1.7 \*\* for patients with normal renal function, activity may be prolonged in patients with renal impairment
Contraindications for Tenecteplase
Metabolic, CTH, suspicious symptoms?
Blood glucose <50 mg/dL or > 400 mg/dL
CT shows frank hypo-density or extensive hypo-attenuation
Symptoms consistent with infective endocarditis
Known or suspected aortic arch dissection
Contraindications for Tenecteplase
GI
Gastrointestinal hemorrhage within previous 21 days
Gastrointestinal malignancy
Contraindications for Tenecteplase
Additional Exclusion Criteria for Onset 3-4.5 Hours (1)
Relative Exclusion Criteria for Onset 3-4.5 hours (3)
Additional Exclusion Criteria for Onset 3-4.5 Hours
Imaging evidence of ischemic injury involving more than 1/3 middle cerebral artery territory
Relative Exclusion Criteria for Onset 3-4.5 hours (3)
NIHSS score > 25
Consider risk vs. benefit:
Oral anticoagulant use
History of prior stroke AND diabetes mellitus
Relative exclusion criteria (11) of Tenecteplase
Major surgery/serious trauma within previous 14 days
Lumbar or arterial puncture in previous 7 days
Recent or active menorrhagia
Pregnancy or post-partum (<14 days)
Hemorrhagic ophthalmic condition
Acute myocardial infarction within 3 months
Other cardiac condition: acute pericarditis, known LV
thrombus, cardiac myxoma, papillary fibroelastoma
Intracranial arterial dissection
Large burden of cerebral micro-bleed on MRI
Current systemic malignancy
Consider risk vs. benefit: (2)
Only NON-DISABLING, mild symptoms; or rapidly improving
stroke symptoms (clearing spontaneously)
Seizure at onset of symptoms, only if residual symptoms
are thought to be post-ictal etiology
Wake up stroke
Steps for workup
- MRI brain without contrast STAT
- Consider Alteplase use
Alteplase adminsitration
- 0.9 mg/Kg (max 90 mg)
10% bolus (max 9mg) over 1 MINUTE Remaining infusion (max 81 mg) over 60 min)
NIHSS
How many sections and subsections?
11 sections
1a-c
2-11
Note: In Section 5 & 6
a = Left
b = Right
NIHSS
“For personal learning”
What are the categories to be tested and where do they fall in the numbering?
1a-c : Mental status
2: Extraocular eye movements
3: Visual Fields
4: Facial Palsy
5: Motor arm
6: Motor Leg
7: Limb Ataxia
8: Sensory
9: Language
10: Dysarthria
11: Extinction and Inattention
NIHSS Scoring Instructions
1a
Level of Consciousness: The investigator must choose a
response if a full evaluation is prevented by such obstacles as an endotracheal tube, language barrier, orotracheal trauma/bandages.
3 is scored only if the patient makes no movement (other than reflexive
posturing) in response to noxious stimulation.
NIHSS Scoring Instructions
1b
1 = unable to speak because of endotracheal intubation, orotracheal trauma, severe
dysarthria from any cause, language barrier or any other problem not secondary to aphasia
2 = Aphasic and stuporous patients who do not comprehend the questions